OpenVSafe by OpenVAERS
Search V-safe

DFH-29568-00396

4 vaccinations 7 coded responses 17 check-ins 7 free-text entries 6 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
787 / TX
Registered
2021-03-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-05
    Dose 1 — Moderna
  2. 2021-03-05
    Registered in v-safe
  3. 2021-03-05
    Dose 2 — Moderna
  4. 2021-03-05
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Itching · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  5. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  7. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-03-12
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  10. 2021-03-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-03-28
    Survey response — day 21, dose 2
    MedDRA: Abdominal discomfort, Gastrooesophageal reflux disease, Migraine, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Migraine, vomiting, GERD
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-28
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-04-02
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-09
    Survey response — day 35, dose 2
    MedDRA: Heavy menstrual bleeding, Menstruation delayed — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Had heavy menstruation the week after second shot. Delayed period now.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-09
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-04-16
    Survey response — day 42, dose 2
    MedDRA: Arthralgia, Heavy menstrual bleeding, Telemedicine — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Heavier and more painful menstruation. Relapse of PTSD (pain in joints from second shot was the trigger). Inflammation and finding in left breast. · Healthcare visit (other): In-person physical and mammogram
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-16
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-06-04
    Survey response — 3 months, dose 2
    MedDRA: Breast inflammation, Lymphadenitis, Mammogram abnormal — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Inflammation of lymph nodes in arm where vaccine was given. Inflammation of breast tissue noted during mammogram.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-06-04
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-09-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-12-16
    Dose 3 — Moderna
    Co-administered: Flu
  22. 2021-12-20
    Call successful
    Not applicable - Accidental Reporting
  23. 2022-04-28
    Dose 4 — Moderna
  24. 2022-04-29
    Survey response — days 1–6 daily, dose 4
    MedDRA: Renal pain — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Kidney pain
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-05-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  26. 2022-05-30
    Survey response — day 28, dose 4
    MedDRA: Diplopia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Monocular diplopia in both eyes. Started intermittently in December after first booster, worsened significantly after second booster on 4/28/22
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-05-30
    Report sent to call center — day 28, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2022-05-31
    Call successful
    Participant prefers to complete VAERS report online
  29. 2022-10-30
    Survey response — 6 months, dose 4
    MedDRA: Anaemia, Cognitive disorder, Diplopia, Inflammation, Ocular discomfort, Office visit, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Severe inflammation, cognitive impairment, double vision (monocular diplopia), blurry vision, pressure behind eyes, tied to inflammation. New severe anemia. Symptoms coincide with onset at 1st Moderna booster, severity increase with 2nd. · Healthcare visit (other): Saw 3 Neurologists, Rheumatologist
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-10-30
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  31. 2022-10-31
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-02-05Moderna
22021-03-05Moderna
32021-12-16Moderna Flu
42022-04-28Moderna No

Call center

6 call center cases

6 successful

See the call center timeline

Free text

Release 6 — day 21, dose 2

2021-03-28

Symptoms: Migraine, vomiting, GERD

Release 7 — day 35, dose 2

2021-04-09

Symptoms: Had heavy menstruation the week after second shot. Delayed period now.

Release 7 — day 42, dose 2

2021-04-16

Symptoms: Heavier and more painful menstruation. Relapse of PTSD (pain in joints from second shot was the trigger). Inflammation and finding in left breast.
Healthcare visit (other): In-person physical and mammogram

Release 8 — 3 months, dose 2

2021-06-04

Symptoms: Inflammation of lymph nodes in arm where vaccine was given. Inflammation of breast tissue noted during mammogram.

Release 11 — days 1–6 daily, dose 4

2022-04-29

Systemic reaction (other): Kidney pain

Release 11 — day 28, dose 4

2022-05-30

Symptoms: Monocular diplopia in both eyes. Started intermittently in December after first booster, worsened significantly after second booster on 4/28/22

Release 12 — 6 months, dose 4

2022-10-30

Symptoms: Severe inflammation, cognitive impairment, double vision (monocular diplopia), blurry vision, pressure behind eyes, tied to inflammation. New severe anemia. Symptoms coincide with onset at 1st Moderna booster, severity increase with 2nd.
Healthcare visit (other): Saw 3 Neurologists, Rheumatologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOTelemedicine ✓ ✓ ✓
SDAbdominal discomfort ○ ✓ ○
SDAnaemia · · ✓
SDArthralgia ✓ ✓ ✓
SDBreast inflammation ✓ ✓ ✓
SDCognitive disorder · · ✓
SDDiplopia · · ✓
SDGastrooesophageal reflux disease ✓ · ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDInflammation · · ✓
SDLymphadenitis ✓ ✓ ✓
SDMammogram abnormal ✓ ✓ ✓
SDMenstruation delayed ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDOcular discomfort · · ✓
SDVision blurred · · ✓
SDVomiting ✓ ✓ ✓
SRORenal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release